Prof. Dr. med. Guido Günther Heinrich Gerken
Professor of Gastroenterology and Hepatology at the University Hospital Essen.
News from the department of Gastroenterology
Latest entry from the department of Gastroenterology:
Vedolizumab Definition Vedolizumab is a gut-selective integrin antagonist approved in May 2014 for use in patients with active moderate to severe forms of Crohn's disease and ulcerative colitis. Vedolizumab is a monoclonal antibody that blocks the adhesion molecule alpha4-beta7 integrin. Pharmaco...Go to article